Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-10

FDA Approved: ANTI-DIARRHEAL/ANTI-GAS CAPLETS — Original Application (YYBA CORP)

View source ↗

Summary

FDA approved YYBA CORP's original application for a combination anti-diarrheal and anti-gas caplet containing loperamide hydrochloride 2 mg and simethicone 125 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANTI-DIARRHEAL/ANTI-GAS CAPLETS (LOPERAMIDE HYDROCHLORIDE 2MG, SIMETHICONE 125MG)

Snippet

ORIG AP for ANTI-DIARRHEAL/ANTI-GAS CAPLETS (LOPERAMIDE HYDROCHLORIDE 2MG, SIMETHICONE 125MG)